US › Healthcare

Bluejay Diagnostics Inc (BJDX)

US · Healthcare · Medical Devices

$1.00+6.12%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Revenue YoY

-100.0%

Net profit

$-1.9M

Profit YoY

-2.9%

EPS

$-1.95

Key statistics

Market cap

$889,854

Forward P/E

0.0

P/B

0.22

Book value

$4.04

EPS (TTM)

$-3.74

52-week high

$16.68

52-week low

$0.83

50-day MA

$2.46

200-day MA

$3.40

Beta

0.88

Analyst view

with an average price target of $256.00.

Shareholding

Insiders

6.07%

Institutions

25.71%

Largest institutional holders

Fund	Stake
Sabby Management LLC	2.78%
Geode Capital Management, LLC	2.72%
Tower Research Capital LLC	0.17%
UBS Group AG	0.01%
L1 Global Manager Pty Ltd	0.01%
Caitong International Asset Management Co., Limited.	0.00%
Meteora Capital, LLC	0.00%
Bank of America Corp	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Bluejay Diagnostics Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.